|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jun 05, 2022 |
Title |
Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance: PTBP1 iCLIP2 in NALM-6 cells |
Organism |
Homo sapiens |
Experiment type |
Other
|
Summary |
We developed a massively parallel reporter assay to determine the splicing effects of all mutations in the region comprising CD19 exons 1-3. Despite the great success of CART-19 (chimeric antigen receptor-armed autologous T-cells) immunotherapy to treat B-cell acute lymphoblastic leukaemia (B-ALL), many patients relapse due to loss of the targeted CD19 epitope. Since epitope loss can be caused by CD19 exon 2 mis-splicing, we set out to learn the regulatory code that controls CD19 alternative splicing.
|
|
|
Overall design |
iCLIP2 protocol performed in NALM-6 cell lines in two replicates under two different RNAse I dilution values
|
|
|
Contributor(s) |
Cortés-López M, Schulz L, Enculescu M, Paret C, Spiekermann B, Busch A, Orekhova A, Kielisch F, Quesnel-Vallières M, Torres-Diz M, Faber J, Barash Y, Thomas-Tikhonenko A, Zarnack K, Legewie S, König J |
Citation(s) |
36138008 |
|
Submission date |
Aug 26, 2021 |
Last update date |
Sep 28, 2022 |
Contact name |
Julian König |
E-mail(s) |
j.koenig@imb-mainz.de
|
Organization name |
Institute of Molecular Biology, Mainz
|
Department |
Biology
|
Lab |
König
|
Street address |
Ackermannweg 4
|
City |
Mainz |
ZIP/Postal code |
55128 |
Country |
Germany |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (4)
|
|
This SubSeries is part of SuperSeries: |
GSE182894 |
Mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance |
|
Relations |
BioProject |
PRJNA758172 |
SRA |
SRP334381 |
Supplementary file |
Size |
Download |
File type/resource |
GSE182893_RAW.tar |
131.8 Mb |
(http)(custom) |
TAR (of BW) |
SRA Run Selector |
Raw data are available in SRA |
Processed data provided as supplementary file |
|
|
|
|
|